Transplant Anesthesia Flashcards
(171 cards)
List the Canadian criteria for the neurological determination of death
- Established etiology capable of causing neurological death in the absence of reversible conditions capable of mimicking neurological death 2. Deep unresponsive coma 3. Absent brainstem reflexes as defined by absent gag and cough reflexes and bilateral absence of: a) motor responses excluding spinal reflexes b) corneal response c) pupillary response to light with pupils at mid size or greater d) vestibular-ocular responses 4. Absent respiratory effort based on apnea test. 5. Absent confounding factors a) umresuscitated shock b) hypothermia (<34) c) severe metabolic disorder capable of causing a potentially reversible come: glucose, electrolytes, inborn errors of metabolism, liver or renal dysfunction d) peripheral nerve or muscle dysfunction or neuromuscular blockade potentially accounting for unresponsiveness e) clinically significant drug intoxications (alcohol, barbiturates, sedatives, hypnotics)
Describe an apnea test and thresholds. What is the ancillary test (ie. in case of COPD and attenuated resp drive)
Period of pre-oxygenation followed by 100% oxygen delivered via the trachea upon discontinuation from mechanical ventilation. Thresholds upon completion of the apnea test (all of): a) PaCO2 >= 60mmHg b) PaCO2 >=20mmHg rise above the pre-apnea test level c) pH <= 7.28 d) no respiratory effort throughout test Ancillary test: global absence of intracranial blood flow
What are the systemic sequelae seen after brain death
1) hemodynamic instability (onset of brain death is associated with a transient period of hypotension with increased cardiac index and tissue perfusion. During this period, vasoactive drugs administered to increase blood pressure can cause rapid circulatory deterioration) 2) autonomic/catecholamine storm accompanies brain herniation 3) wide swings in hormone levels (adrenergic surges causing ischemia and repercussion injuries, followed by pituitary failure) 4) systemic inflammation 5) oxidant stress
Describe a routine donor hormone replacement regimen
1) triiodothyronine (4-µg intravenous [IV] bolus, then 3 µg/hr); 2) methylprednisolone, 15 mg/kg intravenously every 24 hours; 3) desmopressin, 1 U then 0.5 to 4 U/hr to maintain systemic vascular resistance (SVR) at 800 to 1,200 dyne/s/cm 5 (and reduce the polyuria of diabetes insipidus). 4) Insulin infusion to maintain blood glucose 120 to 180 mg/dL
Cardiac cath is requested for which heart donors
male donors >45 years old females >50 years old young donors with significant personal or family history of coronary artery disease.
What additional donor criteria are requested for pHTN recipients
younger donors short ischemic time low donor inotrope requirement oversized organs are preferred.
What criteria must all donor hearts meet
Human leukocyte antigen (HLA) typing ABO blood group compatibility The donor heart size should be within 20% to 30% of the recipient’s heart size.
What are the targets to maintain euvolemia during procurement. Goals of fluid therapy?
1) CVP 6-12mmHg 2) Pulmonary capillary wedge pressure <12mmHg 3) Avoid HES 4) Minimize the use of pressers
What are the blood and electrolyte targets during procurement?
1) Serum sodium levels <155mmol/L 2) Hct > 30% with pRBCs 3) FFP to maintain INR <1.5
What are strategies to maximize donor lung function?
1) bronchoscopy to rule out major pathology 2) Low CVP 3) diuresis prior to procurement 4) glucocorticoids 5) prostaglandin E1 to improve circulation of preservation solution
What are the ideal lung donor characteristics?
Age <55 years ABO compatibility Clear chest radiograph PaO >300 on FiO2 1, PEEP 5 cm H 2 O Tobacco history <20 pack-years Absence of chest trauma No evidence of aspiration or sepsis Negative sputum Gram stain Absence of purulent secretions at bronchoscopy
What donor characteristics are associated with poor outcome?
1) Advanced donor age (>55 years) together with 2) long ischemic time (>6 hours) are associated with poor transplant outcomes 3) poor concordance of height, lung capacity
DCD (deceased after cardiac death) account for what percentage of organ transplants?
10.6%
What are the DCD criteria?
1) unresponsiveness - often have severe whole-brain dysfunction but have electrical activity in the brain 2) apnea 3) permanent cessation of circulation and respiration (arterial monitoring showing pulse pressure of zero, or Doppler showing no flow) (The ACCCM argues that no less than 2 minutes is acceptable and no more than 5 minutes is necessary when determining death for potential DCD. )
What is a routine fluid load for living kidney donors?
A reasonable fluid protocol is to administer crystalloid at 10 mL/kg/ hr above calculated losses and to maintain urine output at about 100 mL/hr. Fluid loading overnight before surgery (vs. fluid administration starting with surgery) is associated with better creatinine clearance during the procedure, but this advantage is lost by postoperative day 2.
What is concerning regarding post-op pain management in living kidney donors?
1/3 have chronic pain
Regarding living liver donors, which procedure is most complex?
Left lateral segmentectomy (II and III) is used when adults are donating to children and are usually well tolerated. Right hepatectomy is required for adult-to-adult liver transplantation and is a major operation with significant risk. Complication rate 30%, morality of 0.2-0.5%.
The residual liver volume of the donor must be ____ of original volume to prevent “small for size” syndrome in the donor.
>35%
What are the complications of right hepatectomy donation?
air embolism, atelectasis, pneumonia, and biliary tract damage
What is the main intraoperative challenge for living liver donors?
Large liver resections may require virtually complete hepatic venous exclusion (cross-clamping of the hepatic pedicle usually without cava clamping). Not unexpectedly, venous return falls significantly because patients are healthy and without collaterals. But fluid boluses increase CVP which can increase bleeding. If vasopressors are needed, use vasopressin or levo.
What are the postoperative challenges after living liver donation?
- Pain control: INR peaks on POD1-3 when catheter would be removed. 2. Hypophosphatemia: Due to excessive loss in urine. Treat with sodium phosphate infusions to maintain phosphate levels 3.5-5.4mg/dL. 3. Elevated liver enzymes: typically return to normal in 3 months
What are the criteria for living lung donation?
Member of recipient’s extended family Age 18–55 years No prior thoracic surgery on donor side Good general health Taller than recipient preferred ABO compatible FVC and FEV 1 >85% predicted PO >80 mm Hg on room air No chronic viral diseases Normal electrocardiogram and echocardiogram Normal stress test in donors older than 40 years old
Why is immunosuppression a delicate balance?
Immunosuppressed patients who are undertreated risk rejection; overimmunosuppression can be toxic, especially to the kidneys.
What are the major risks of immunosuppression?
CNS: lower seizure threshold CV: DM, HTN, hyperlipidemia, atherosclerosis Renal: decreased eGFR, hyperkalemia, hypomagnesemia Heamtological: increased risk of infection and malignancy, pancytopenia Endocrine: Osteoperosis, poor wound healing


